EP2285808 - SPIRO-INDOLE DERIVATIVES FOR THE TREATMENT OF PARASITIC DISEASES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 26.09.2014 Database last updated on 13.07.2024 | Most recent event Tooltip | 26.09.2014 | No opposition filed within time limit | published on 29.10.2014 [2014/44] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [2011/08] | Inventor(s) | 01 /
ANG, Shi Hua Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos Singapore 138670 / SG | 02 /
KRASTEL, Philipp Novartis Pharma AG Postfach CH-4002 Basel / CH | 03 /
LEONG, Seh Yong Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos Singapore 138670 / SG | 04 /
TAN, Liying Jocelyn Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos Singapore 138670 / SG | 05 /
WONG, Wei Lin Josephine Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos Singapore 138670 / SG | 06 /
YEUNG, Bryan KS Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos Singapore 138670 / SG | 07 /
ZOU, Bin Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos Singapore 138670 / SG | [2013/47] |
Former [2011/08] | 01 /
ANG, Shi Hua Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos Singapore 138670 / SG | ||
02 /
KRASTEL, Philipp Novartis Pharma AG Postfach CH-4002 Basel / CH | |||
03 /
LEONG, Seh Yong Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos Singapore 138670 / SG | |||
04 /
TAN, Liying Jocelyn Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos Singapore 138670 / SG | |||
05 /
WONG, Wei Lin Josephine Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos Singapore 138670 / SG | |||
06 /
YEUNG, Bryan KS Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos Singapore 138670 / SG | |||
07 /
ZOU, Bin Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos Singapore 138670 / SG | Representative(s) | Stuttle, James Henry Phillip Novartis Pharma AG Patent Department 4002 Basel / CH | [2014/01] |
Former [2013/47] | Warner, James Alexander Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | ||
Former [2011/08] | Warner, James Alexander Carpmaels & Ransford One Southampton Row London WC1B 5HA / GB | Application number, filing date | 09737965.5 | 01.04.2009 | [2011/08] | WO2009EP53902 | Priority number, date | EP20080155342 | 29.04.2008 Original published format: EP 08155342 | EP20090151117 | 22.01.2009 Original published format: EP 09151117 | [2011/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009132921 | Date: | 05.11.2009 | Language: | EN | [2009/45] | Type: | A1 Application with search report | No.: | EP2285808 | Date: | 23.02.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.11.2009 takes the place of the publication of the European patent application. | [2011/08] | Type: | B1 Patent specification | No.: | EP2285808 | Date: | 20.11.2013 | Language: | EN | [2013/47] | Search report(s) | International search report - published on: | EP | 05.11.2009 | Classification | IPC: | C07D471/20, C07D487/20, A61K31/437, A61K31/55, A61K31/407, A61P33/02, A61P33/06, A61K31/424, A61K31/438, C07D498/22 | [2011/08] | CPC: |
C07D471/20 (EP,US);
A61P31/00 (EP);
A61P33/00 (EP);
A61P33/02 (EP);
A61P33/06 (EP);
A61P43/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2011/08] | Title | German: | SPIRO-INDOLDERIVATE ZUR BEHANDLUNG PARASITISCHER KRANKHEITEN | [2011/08] | English: | SPIRO-INDOLE DERIVATIVES FOR THE TREATMENT OF PARASITIC DISEASES | [2011/08] | French: | DÉRIVÉS SPIRO-INDOLES POUR LE TRAITEMENT DE MALADIES PARASITAIRES | [2011/08] | Entry into regional phase | 10.11.2010 | National basic fee paid | 10.11.2010 | Designation fee(s) paid | 10.11.2010 | Examination fee paid | Examination procedure | 10.11.2010 | Examination requested [2011/08] | 09.02.2011 | Amendment by applicant (claims and/or description) | 11.04.2012 | Despatch of a communication from the examining division (Time limit: M04) | 21.08.2012 | Reply to a communication from the examining division | 25.02.2013 | Despatch of a communication from the examining division (Time limit: M04) | 05.06.2013 | Reply to a communication from the examining division | 30.08.2013 | Communication of intention to grant the patent | 02.10.2013 | Fee for grant paid | 02.10.2013 | Fee for publishing/printing paid | Divisional application(s) | EP13185962.1 / EP2722333 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 11.04.2012 | Opposition(s) | 21.08.2014 | No opposition filed within time limit [2014/44] | Fees paid | Renewal fee | 12.04.2011 | Renewal fee patent year 03 | 30.03.2012 | Renewal fee patent year 04 | 12.04.2013 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]EP0466548 (ADIR [FR]) [X] 1-3,6,7 * page 8; example 1 * * claim 5 *; | [A]WO2005009370 (PHARMACIA CORP [US], et al) [A] 1-3,5-7 * page 6 - page 8; compound I * * page 300, paragraph 143 ** claim 12 *; | [X] - BREMNER JOHN B ET AL, "A compact approach to an isomeric iheyamine a system and x-ray crystal structure of 5-methyl-5H-azepino[2,3-b:4,5-b']diindole", SYNTHETIC COMMUNICATIONS, TAYLOR & FRANCIS GROUP, PHILADELPHIA, PA, vol. 38, no. 12, ISSN 0039-7911, (20080101), pages 1931 - 1939, (20080101), XP009115559 [X] 1-3 * page 1932; compound 5B * DOI: http://dx.doi.org/10.1080/00397910801997603 | [A] - CHIYANZU IDAN ET AL, "Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER SCIENCE LTD, GB, (20050101), vol. 13, no. 9, ISSN 0968-0896, pages 3249 - 3261, XP002482130 [A] 1-13 * the whole document * DOI: http://dx.doi.org/10.1016/j.bmc.2005.02.037 | [A] - HUDSON, A.T., "Patent focus on antiparasitic agents", EXPERT OPINION ON THERAPEUTIC PATENTS, (20000101), vol. 10, no. 2, pages 153 - 163, XP002527893 [A] 1-13 * the whole document * DOI: http://dx.doi.org/10.1517/13543776.10.2.153 | Examination | - GRIGORYAN N P ET AL, "Synthesis and antispasmodic activity of spiro[.beta.-carbolineindolo nes] and spiro[indoleindolo[2,3-c]azepinones]", HAYASTANI KIMIAKAN HANDES, IZDATEL'STVO GITUTYN NAN RESPUBLIKI ARMENII, (20050101), vol. 58, no. 3, ISSN 1561-4190, pages 100 - 104, XP009102457 |